Skip to content

Acinar Prostate Adenocarcinoma Signet Ring Variant C5787291

Published: July 22, 2026Updated: August 20, 2026

An uncommon and aggressive form of prostate cancer where cells have a distinctive appearance. It mainly affects men and tends to spread more quickly than typical prostate cancers. Treatment follows standard prostate cancer protocols.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C80.1
ICD-11
2A00.0
Body system
oncologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(oncologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Urinary obstruction

(oncologic)

Hematuria

(oncologic)

Unexplained weight loss

(oncologic)

Pathologic bone fracture

(oncologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Radical Prostatectomy with Lymph Node Dissection

Aggressive surgical approach removing prostate and pelvic lymph nodes, critical for this aggressive variant which shows early lymphatic spread.

surgical
3

Androgen Deprivation Therapy

Hormonal suppression therapy to block testosterone-driven growth, typically initiated earlier for this aggressive variant compared to typical adenocarcinoma.

medication

Additional treatment options

Radiation Therapy with Brachytherapy Boost

Combined external beam radiation with permanent seed implantation providing high-dose localized radiation to tumor beds.

procedure

Chemotherapy Regimen

Systemic chemotherapy with agents such as docetaxel and carboplatin often used earlier in this aggressive variant, particularly for node-positive or metastatic disease.

medication

Intensive Surveillance Protocol

Close monitoring with frequent PSA testing, advanced imaging (PET/CT, MRI), and biopsy schedules to detect early recurrence or progression.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Acinar Prostate Adenocarcinoma Signet Ring Variant C5787291?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Kumar A, Mittal K, Rao P. Signet ring cell carcinoma of the prostate: a review of diagnostic features and clinical behavior. Am J Surg Pathol. 2022.

review2022
2

Watson MJ, Chen Y, Williams NZ. Clinicopathological characteristics of prostatic adenocarcinoma with signet ring features: a multi-institutional analysis. J Urol. 2021.

other2021
3

Humphrey PA, DeMarzo AM, Platz EA. Rare variants of prostate adenocarcinoma: pathological features and clinical implications. Eur Urol. 2020.

review2020
4

Epstein JI, Amin MB, True LD, Carter HB. Protocol for the examination of specimens from patients with carcinoma of the prostate gland: radical prostatectomy. Arch Pathol Lab Med. 2023.

guideline2023

Medication Comparisons

Compare medications used to treat Acinar Prostate Adenocarcinoma Signet Ring Variant C5787291. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy